You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Pancreatic Cancer Diagnostic Market Research Report 2021, Competitive Analysis, Industry Growth Trends And Forecast 2027

Pancreatic cancer is expected to become the second deadliest cancer in the United States by 2030. It is tough to cure because it is usually not discovered until it has reached an advanced stage. This report studies the Pancreatic Cancer Diagnostic market, includes Tumor Biomarker Tests, Imaging, Biopsy and other products.
United States is the largest sales place, with a consumption value market share nearly 32.12% in 2017. Following United States, Europe is the second largest sales place with the consumption market share of 27.65%.
Market competition is intense. Roche, GE Healthcare, Siemens, BD, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
In 2017, the global Pancreatic Cancer Diagnostic market size was 1930 million US$ and it is expected to reach 3590 million US$ by the end of 2025, with a CAGR of 8.1% during 2018-2025.
This report focuses on the global Pancreatic Cancer Diagnostic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pancreatic Cancer Diagnostic development in United States, Europe and China.


The key players covered in this study
Roche
GE Healthcare
Siemens
BD
Philips Healthcare
Hitachi Medical
Danaher
Abbott
Canon Medical Systems
Myriad Genetics
Qiagen
Asuragen
BioMarker Strategies

Market segment by Type, the product can be split into
Imaging
Tumor Biomarker
Biopsy
Other

Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Pancreatic Cancer Diagnostic status, future forecast, growth opportunity, key market and key players.
To present the Pancreatic Cancer Diagnostic development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Pancreatic Cancer Diagnostic are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Pancreatic Cancer Diagnostic Market Size Growth Rate by Type (2013-2025)
1.4.2 Imaging
1.4.3 Tumor Biomarker
1.4.4 Biopsy
1.4.5 Other
1.5 Market by Application
1.5.1 Global Pancreatic Cancer Diagnostic Market Share by Application (2013-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Pancreatic Cancer Diagnostic Market Size
2.2 Pancreatic Cancer Diagnostic Growth Trends by Regions
2.2.1 Pancreatic Cancer Diagnostic Market Size by Regions (2013-2025)
2.2.2 Pancreatic Cancer Diagnostic Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Pancreatic Cancer Diagnostic Market Size by Manufacturers
3.1.1 Global Pancreatic Cancer Diagnostic Revenue by Manufacturers (2013-2018)
3.1.2 Global Pancreatic Cancer Diagnostic Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Pancreatic Cancer Diagnostic Market Concentration Ratio (CR5 and HHI)
3.2 Pancreatic Cancer Diagnostic Key Players Head office and Area Served
3.3 Key Players Pancreatic Cancer Diagnostic Product/Solution/Service
3.4 Date of Enter into Pancreatic Cancer Diagnostic Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Pancreatic Cancer Diagnostic Market Size by Type (2013-2018)
4.2 Global Pancreatic Cancer Diagnostic Market Size by Application (2013-2018)

5 United States
5.1 United States Pancreatic Cancer Diagnostic Market Size (2013-2018)
5.2 Pancreatic Cancer Diagnostic Key Players in United States
5.3 United States Pancreatic Cancer Diagnostic Market Size by Type
5.4 United States Pancreatic Cancer Diagnostic Market Size by Application

6 Europe
6.1 Europe Pancreatic Cancer Diagnostic Market Size (2013-2018)
6.2 Pancreatic Cancer Diagnostic Key Players in Europe
6.3 Europe Pancreatic Cancer Diagnostic Market Size by Type
6.4 Europe Pancreatic Cancer Diagnostic Market Size by Application

7 China
7.1 China Pancreatic Cancer Diagnostic Market Size (2013-2018)
7.2 Pancreatic Cancer Diagnostic Key Players in China
7.3 China Pancreatic Cancer Diagnostic Market Size by Type
7.4 China Pancreatic Cancer Diagnostic Market Size by Application

8 Japan
8.1 Japan Pancreatic Cancer Diagnostic Market Size (2013-2018)
8.2 Pancreatic Cancer Diagnostic Key Players in Japan
8.3 Japan Pancreatic Cancer Diagnostic Market Size by Type
8.4 Japan Pancreatic Cancer Diagnostic Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Pancreatic Cancer Diagnostic Market Size (2013-2018)
9.2 Pancreatic Cancer Diagnostic Key Players in Southeast Asia
9.3 Southeast Asia Pancreatic Cancer Diagnostic Market Size by Type
9.4 Southeast Asia Pancreatic Cancer Diagnostic Market Size by Application

10 India
10.1 India Pancreatic Cancer Diagnostic Market Size (2013-2018)
10.2 Pancreatic Cancer Diagnostic Key Players in India
10.3 India Pancreatic Cancer Diagnostic Market Size by Type
10.4 India Pancreatic Cancer Diagnostic Market Size by Application

11 Central & South America
11.1 Central & South America Pancreatic Cancer Diagnostic Market Size (2013-2018)
11.2 Pancreatic Cancer Diagnostic Key Players in Central & South America
11.3 Central & South America Pancreatic Cancer Diagnostic Market Size by Type
11.4 Central & South America Pancreatic Cancer Diagnostic Market Size by Application

12 International Players Profiles
12.1 Roche
12.1.1 Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Pancreatic Cancer Diagnostic Introduction
12.1.4 Roche Revenue in Pancreatic Cancer Diagnostic Business (2013-2018)
12.1.5 Roche Recent Development
12.2 GE Healthcare
12.2.1 GE Healthcare Company Details
12.2.2 Company Description and Business Overview
12.2.3 Pancreatic Cancer Diagnostic Introduction
12.2.4 GE Healthcare Revenue in Pancreatic Cancer Diagnostic Business (2013-2018)
12.2.5 GE Healthcare Recent Development
12.3 Siemens
12.3.1 Siemens Company Details
12.3.2 Company Description and Business Overview
12.3.3 Pancreatic Cancer Diagnostic Introduction
12.3.4 Siemens Revenue in Pancreatic Cancer Diagnostic Business (2013-2018)
12.3.5 Siemens Recent Development
12.4 BD
12.4.1 BD Company Details
12.4.2 Company Description and Business Overview
12.4.3 Pancreatic Cancer Diagnostic Introduction
12.4.4 BD Revenue in Pancreatic Cancer Diagnostic Business (2013-2018)
12.4.5 BD Recent Development
12.5 Philips Healthcare
12.5.1 Philips Healthcare Company Details
12.5.2 Company Description and Business Overview
12.5.3 Pancreatic Cancer Diagnostic Introduction
12.5.4 Philips Healthcare Revenue in Pancreatic Cancer Diagnostic Business (2013-2018)
12.5.5 Philips Healthcare Recent Development
12.6 Hitachi Medical
12.6.1 Hitachi Medical Company Details
12.6.2 Company Description and Business Overview
12.6.3 Pancreatic Cancer Diagnostic Introduction
12.6.4 Hitachi Medical Revenue in Pancreatic Cancer Diagnostic Business (2013-2018)
12.6.5 Hitachi Medical Recent Development
12.7 Danaher
12.7.1 Danaher Company Details
12.7.2 Company Description and Business Overview
12.7.3 Pancreatic Cancer Diagnostic Introduction
12.7.4 Danaher Revenue in Pancreatic Cancer Diagnostic Business (2013-2018)
12.7.5 Danaher Recent Development
12.8 Abbott
12.8.1 Abbott Company Details
12.8.2 Company Description and Business Overview
12.8.3 Pancreatic Cancer Diagnostic Introduction
12.8.4 Abbott Revenue in Pancreatic Cancer Diagnostic Business (2013-2018)
12.8.5 Abbott Recent Development
12.9 Canon Medical Systems
12.9.1 Canon Medical Systems Company Details
12.9.2 Company Description and Business Overview
12.9.3 Pancreatic Cancer Diagnostic Introduction
12.9.4 Canon Medical Systems Revenue in Pancreatic Cancer Diagnostic Business (2013-2018)
12.9.5 Canon Medical Systems Recent Development
12.10 Myriad Genetics
12.10.1 Myriad Genetics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Pancreatic Cancer Diagnostic Introduction
12.10.4 Myriad Genetics Revenue in Pancreatic Cancer Diagnostic Business (2013-2018)
12.10.5 Myriad Genetics Recent Development
12.11 Qiagen
12.12 Asuragen
12.13 BioMarker Strategies

13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 101